The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of Nuclear Medicine
Authors:
- on behalf of the EANM and the EANM Thyroid CommitteeOCon behalf of the EANM and the EANM Thyroid Committee
- Giorgio TregliaGiorgio Treglia
- Cumali AktolunCACumali Aktolun
- Arturo ChitiACArturo Chiti
- Ioannis IakovouIoannis Iakovou
- 27 April 2016
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (8) , 1486-1490
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancerNuclear Medicine Communications, 2013
- Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission TomographyAcademic Radiology, 2012
- PET Imaging in Recurrent Medullary Thyroid CarcinomaInternational Journal of Molecular Imaging, 2012
- Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancerNuclear Medicine Communications, 2012
- Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinomaNuclear Medicine Communications, 2012
- How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticalsNuclear Medicine Communications, 2012
- 2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid CancerEuropean Thyroid Journal, 2012
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid AssociationThyroid®, 2009
- Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinomaBiomedicine & Pharmacotherapy, 2008
- Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin LevelsThe Journal of Clinical Endocrinology & Metabolism, 2007